Pros and Cons of Monoclonal Antibodies Fixed Dosing Administration in Cancer Patients

Alfredo Tartarone, Rosa Lerose and Michele Aieta
Additional contact information
Michele Aieta: Department of Onco-Hematology, IRCCS-CROB Referral Cancer Center of Basilicata, Italy

Biomedical Journal of Scientific & Technical Research, 2018, vol. 4, issue 2, 3785-3786

Abstract: Monoclonal antibodies (mAbs) in oncology are usually administered in body-size-based or fixed dosing schedules...

Keywords: Biomedical Sciences; Biomedical Research; Technical research (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.001015.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.001015.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:4:y:2018:i:2:p:3785-3786

DOI: 10.26717/BJSTR.2018.04.001015

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().